• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性透明细胞肾细胞癌(ccRCC)中的基因组结构重塑:一种新范式及个性化基因治疗方法的建议

Genomic Fabric Remodeling in Metastatic Clear Cell Renal Cell Carcinoma (ccRCC): A New Paradigm and Proposal for a Personalized Gene Therapy Approach.

作者信息

Iacobas Dumitru A, Mgbemena Victoria E, Iacobas Sanda, Menezes Kareena M, Wang Huichen, Saganti Premkumar B

机构信息

Personalized Genomics Laboratory, CRI Center for Computational Systems Biology, Roy G Perry College of Engineering, Prairie View A&M University, Prairie View, TX 77446, USA.

Department of Biology, MD and S Brailsford College of Arts and Sciences, Prairie View A&M University, Prairie View, TX 77446, USA.

出版信息

Cancers (Basel). 2020 Dec 8;12(12):3678. doi: 10.3390/cancers12123678.

DOI:10.3390/cancers12123678
PMID:33302383
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7762545/
Abstract

Published transcriptomic data from surgically removed metastatic clear cell renal cell carcinoma samples were analyzed from the genomic fabric paradigm (GFP) perspective to identify the best targets for gene therapy. GFP considers the transcriptome as a multi-dimensional mathematical object constrained by a dynamic set of expression controls and correlations among genes. Every gene in the chest wall metastasis, two distinct cancer nodules, and the surrounding normal tissue of the right kidney was characterized by three independent measures: average expression level, relative expression variation, and expression correlation with each other gene. The analyses determined the cancer-induced regulation, control, and remodeling of the chemokine and vascular endothelial growth factor (VEGF) signaling, apoptosis, basal transcription factors, cell cycle, oxidative phosphorylation, renal cell carcinoma, and RNA polymerase pathways. Interestingly, the three cancer regions exhibited different transcriptomic organization, suggesting that the gene therapy should not be personalized only for every patient but also for each major cancer nodule. The gene hierarchy was established on the basis of gene commanding height, and the gene master regulators , and were identified in each profiled region. We delineated the molecular mechanisms by which overexpression and silencing would selectively affect the cancer cells with little consequences for the normal cells.

摘要

从基因组结构范式(GFP)的角度分析了手术切除的转移性透明细胞肾细胞癌样本的已发表转录组数据,以确定基因治疗的最佳靶点。GFP将转录组视为一个多维数学对象,受一组动态的表达控制和基因间相关性的约束。通过三个独立指标对胸壁转移灶、两个不同的癌结节以及右肾周围正常组织中的每个基因进行了表征:平均表达水平、相对表达变异以及与其他每个基因的表达相关性。分析确定了趋化因子和血管内皮生长因子(VEGF)信号传导、细胞凋亡、基础转录因子、细胞周期、氧化磷酸化、肾细胞癌和RNA聚合酶途径的癌症诱导调节、控制和重塑。有趣的是,这三个癌区表现出不同的转录组组织,这表明基因治疗不仅应该针对每个患者进行个性化定制,还应该针对每个主要癌结节进行个性化定制。基于基因指挥高度建立了基因层次结构,并在每个分析区域中鉴定了基因主调控因子 、 和 。我们阐述了 过表达和 沉默将如何选择性地影响癌细胞而对正常细胞几乎没有影响的分子机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3696/7762545/6ec39ec80972/cancers-12-03678-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3696/7762545/6de25da085d5/cancers-12-03678-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3696/7762545/e296b27fe6f3/cancers-12-03678-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3696/7762545/cd6d30810430/cancers-12-03678-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3696/7762545/952889591fc0/cancers-12-03678-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3696/7762545/cd6c3e55767f/cancers-12-03678-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3696/7762545/55c0f5472b75/cancers-12-03678-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3696/7762545/bda87691f04e/cancers-12-03678-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3696/7762545/6ec39ec80972/cancers-12-03678-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3696/7762545/6de25da085d5/cancers-12-03678-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3696/7762545/e296b27fe6f3/cancers-12-03678-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3696/7762545/cd6d30810430/cancers-12-03678-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3696/7762545/952889591fc0/cancers-12-03678-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3696/7762545/cd6c3e55767f/cancers-12-03678-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3696/7762545/55c0f5472b75/cancers-12-03678-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3696/7762545/bda87691f04e/cancers-12-03678-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3696/7762545/6ec39ec80972/cancers-12-03678-g008.jpg

相似文献

1
Genomic Fabric Remodeling in Metastatic Clear Cell Renal Cell Carcinoma (ccRCC): A New Paradigm and Proposal for a Personalized Gene Therapy Approach.转移性透明细胞肾细胞癌(ccRCC)中的基因组结构重塑:一种新范式及个性化基因治疗方法的建议
Cancers (Basel). 2020 Dec 8;12(12):3678. doi: 10.3390/cancers12123678.
2
Genomic Fabrics of the Excretory System's Functional Pathways Remodeled in Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌中重塑的排泄系统功能通路的基因组结构
Curr Issues Mol Biol. 2023 Nov 24;45(12):9471-9499. doi: 10.3390/cimb45120594.
3
A Personalized Genomics Approach of the Prostate Cancer.前列腺癌的个性化基因组学方法
Cells. 2021 Jun 30;10(7):1644. doi: 10.3390/cells10071644.
4
The Gene Master Regulators (GMR) Approach Provides Legitimate Targets for Personalized, Time-Sensitive Cancer Gene Therapy.基因主调控因子(GMR)方法为个性化、时间敏感的癌症基因治疗提供了合理的靶点。
Genes (Basel). 2019 Jul 25;10(8):560. doi: 10.3390/genes10080560.
5
Powerful quantifiers for cancer transcriptomics.用于癌症转录组学的强大定量方法。
World J Clin Oncol. 2020 Sep 24;11(9):679-704. doi: 10.5306/wjco.v11.i9.679.
6
Personalized 3-Gene Panel for Prostate Cancer Target Therapy.用于前列腺癌靶向治疗的个性化三基因检测板
Curr Issues Mol Biol. 2022 Jan 15;44(1):360-382. doi: 10.3390/cimb44010027.
7
Identification and validation of novel prognostic markers in Renal Cell Carcinoma.肾细胞癌中新型预后标志物的鉴定与验证
Dan Med J. 2017 Oct;64(10).
8
Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.血管内皮生长因子-B和血管内皮生长因子-C在肾细胞癌中的表达:受希佩尔-林道基因和缺氧调控
Cancer Res. 2001 Apr 1;61(7):3206-11.
9
Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine.从透明细胞肾细胞癌患者中高效生成患者匹配的恶性和正常原代细胞培养物:用于研究和个性化医疗的临床相关模型
BMC Cancer. 2016 Jul 16;16:485. doi: 10.1186/s12885-016-2539-z.
10
Phenotypic drug screening and target validation for improved personalized therapy reveal the complexity of phenotype-genotype correlations in clear cell renal cell carcinoma.用于改善个性化治疗的表型药物筛选和靶点验证揭示了透明细胞肾细胞癌中表型-基因型相关性的复杂性。
Urol Oncol. 2014 Aug;32(6):877-84. doi: 10.1016/j.urolonc.2014.03.011. Epub 2014 Jun 11.

引用本文的文献

1
DSS1 inhibits autophagy to activate epithelial-mesenchymal transition in a pro-metastatic niche of renal cell carcinoma.DSS1通过抑制自噬来激活肾细胞癌促转移微环境中的上皮-间质转化。
Nat Commun. 2025 Jul 23;16(1):6769. doi: 10.1038/s41467-025-62135-9.
2
Papillary Thyroid Cancer Remodels the Genetic Information Processing Pathways.甲状腺乳头癌重塑遗传信息处理途径。
Genes (Basel). 2024 May 14;15(5):621. doi: 10.3390/genes15050621.
3
Low-Salt Diet Regulates the Metabolic and Signal Transduction Genomic Fabrics, and Remodels the Cardiac Normal and Chronic Pathological Pathways.

本文引用的文献

1
Powerful quantifiers for cancer transcriptomics.用于癌症转录组学的强大定量方法。
World J Clin Oncol. 2020 Sep 24;11(9):679-704. doi: 10.5306/wjco.v11.i9.679.
2
TASOR is a pseudo-PARP that directs HUSH complex assembly and epigenetic transposon control.TASOR 是一种伪 PARP,可指导 HUSH 复合物组装和表观遗传转座子控制。
Nat Commun. 2020 Oct 2;11(1):4940. doi: 10.1038/s41467-020-18761-6.
3
Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.载脂蛋白C1(APOC1):一种用于透明细胞肾细胞癌的新型诊断和预后生物标志物。
低盐饮食调节代谢和信号转导基因组结构,并重塑心脏正常和慢性病理通路。
Curr Issues Mol Biol. 2024 Mar 12;46(3):2355-2385. doi: 10.3390/cimb46030150.
4
CRISPR-Based Therapies: Revolutionizing Drug Development and Precision Medicine.基于 CRISPR 的疗法:颠覆药物研发和精准医学。
Curr Gene Ther. 2024;24(3):193-207. doi: 10.2174/0115665232275754231204072320.
5
Genomic Fabrics of the Excretory System's Functional Pathways Remodeled in Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌中重塑的排泄系统功能通路的基因组结构
Curr Issues Mol Biol. 2023 Nov 24;45(12):9471-9499. doi: 10.3390/cimb45120594.
6
Theory and Applications of the (Cardio) Genomic Fabric Approach to Post-Ischemic and Hypoxia-Induced Heart Failure.(心脏)基因组结构方法在缺血后和缺氧诱导性心力衰竭中的理论与应用
J Pers Med. 2022 Jul 29;12(8):1246. doi: 10.3390/jpm12081246.
7
Personalized 3-Gene Panel for Prostate Cancer Target Therapy.用于前列腺癌靶向治疗的个性化三基因检测板
Curr Issues Mol Biol. 2022 Jan 15;44(1):360-382. doi: 10.3390/cimb44010027.
8
From Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immune Response to Cancer Onset via Molecular Mimicry and Cross-Reactivity.从抗严重急性呼吸综合征冠状病毒2免疫反应到通过分子模拟和交叉反应引发癌症
Glob Med Genet. 2021 Sep 7;8(4):176-182. doi: 10.1055/s-0041-1735590. eCollection 2021 Dec.
9
A Personalized Genomics Approach of the Prostate Cancer.前列腺癌的个性化基因组学方法
Cells. 2021 Jun 30;10(7):1644. doi: 10.3390/cells10071644.
10
Transcriptomic uniqueness and commonality of the ion channels and transporters in the four heart chambers.转录组在四个心腔中的离子通道和转运蛋白的独特性和共性。
Sci Rep. 2021 Feb 2;11(1):2743. doi: 10.1038/s41598-021-82383-1.
Front Oncol. 2020 Aug 20;10:1436. doi: 10.3389/fonc.2020.01436. eCollection 2020.
4
Identification and validation of novel metastasis-related signatures of clear cell renal cell carcinoma using gene expression databases.利用基因表达数据库鉴定和验证透明细胞肾细胞癌新的转移相关特征
Am J Transl Res. 2020 Aug 15;12(8):4108-4126. eCollection 2020.
5
Biomarkers, Master Regulators and Genomic Fabric Remodeling in a Case of Papillary Thyroid Carcinoma.在甲状腺乳头状癌病例中,生物标志物、主调控因子和基因组结构重塑。
Genes (Basel). 2020 Sep 2;11(9):1030. doi: 10.3390/genes11091030.
6
Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells.肌动蛋白结合蛋白 Profilin1 促进肾透明细胞癌细胞的侵袭能力。
J Biol Chem. 2020 Nov 13;295(46):15636-15649. doi: 10.1074/jbc.RA120.013963. Epub 2020 Sep 3.
7
Serum tumour associated trypsin inhibitor, as a biomarker for survival in renal cell carcinoma.血清肿瘤相关胰蛋白酶抑制剂作为肾细胞癌生存的生物标志物。
Scand J Urol. 2020 Oct;54(5):413-419. doi: 10.1080/21681805.2020.1798501. Epub 2020 Aug 4.
8
Exploiting the circuit breaker cancer evolution model in human clear cell renal cell carcinoma.在人类透明细胞肾细胞癌中利用断路器癌症进化模型。
Cell Stress. 2020 Jun 25;4(8):191-198. doi: 10.15698/cst2020.08.227.
9
Pathway Analysis of Renal Cell Carcinoma Genome-Wide Association Studies Identifies Novel Associations.全基因组关联研究分析肾细胞癌通路,鉴定出新的关联。
Cancer Epidemiol Biomarkers Prev. 2020 Oct;29(10):2065-2069. doi: 10.1158/1055-9965.EPI-20-0472. Epub 2020 Jul 30.
10
Integrated bioinformatics analysis for the identification of potential key genes affecting the pathogenesis of clear cell renal cell carcinoma.用于鉴定影响透明细胞肾细胞癌发病机制的潜在关键基因的综合生物信息学分析
Oncol Lett. 2020 Aug;20(2):1573-1584. doi: 10.3892/ol.2020.11703. Epub 2020 Jun 5.